Giuseppe Caff
Soft tissue sarcomas (STS) are rare neoplasms (1% of all cancers in US with a prevalence of 10520 new cases/year) although there are more than 50 different histological type.The current management of STS is addressed to excision of the tumor and to preserve limb function as better as possible; respectingthis balance has been always a challenge for the orthopedic oncology and the importance of treating patients with such sarcomas with wideradical resections obtaining negative pathological margins has beenunderlined in many studies.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 